Smoothened antagonism for the treatment of hedgehog pathway-related disorders

Details for Australian Patent Application No. 2009299927 (hide)

Owner Novartis AG

Inventors Dorsch, Marion; Monahan, John E.; Morrissey, Michael Patrick; Pan, Shifeng; Williams, Juliet

Agent Davies Collison Cave

Pub. Number AU-A-2009299927

PCT Pub. Number WO2010/037715

Priority 61/101,851 01.10.08 US; 61/101,858 01.10.08 US

Filing date 28 September 2009

Wipo publication date 8 April 2010

International Classifications

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/4184 (2006.01)

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4433 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

31 March 2011 PCT application entered the National Phase

  PCT publication WO2010/037715 Priority application(s): WO2010/037715

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009299983-Instrument for handling a joint component by way of a vacuum

2009299926-Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance biotic stress